Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


04.10.2021

1 Am J Epidemiol
1 Ann Oncol
1 Ann Surg
4 Ann Surg Oncol
5 Ann Thorac Surg
4 Anticancer Res
1 BMC Cancer
4 Br J Cancer
4 Cancer Cell
2 Carcinogenesis
1 Chest
3 Clin Lung Cancer
1 Eur J Cancer
1 Eur Respir J
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Surg Oncol
3 J Thorac Oncol
5 Lung Cancer
1 Mol Cancer Ther
1 Mol Carcinog
1 Oncologist
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Epidemiol

  1. SANYAL N, Napolioni V, de Rochemonteix M, Belloy ME, et al
    A Robust Test for Additive Gene-Environment Interaction Under the Trend Effect of Genotype Using an Empirical Bayes-Type Shrinkage Estimator.
    Am J Epidemiol. 2021;190:1948-1960.
    PubMed         Abstract available


    Ann Oncol

  2. PETERS S, Pujol JL, Dafni U, Domine M, et al
    Consolidation nivolumab and ipilimumab versus observation in limited-disease small cell lung cancer after chemo-radiotherapy - Results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
    Ann Oncol. 2021 Sep 22. pii: S0923-7534(21)04490.
    PubMed         Abstract available


    Ann Surg

  3. DENG H, Liu J, Cai X, Chen J, et al
    Radical Minimally invasive surgery following immuno-chemotherapy in Initially-unresectable stage IIIB Non-small cell lung cancer.
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93263.
    PubMed         Abstract available


    Ann Surg Oncol

  4. WEI X, Yu H, Dai W, Mu Y, et al
    Correction to: Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10798.
    PubMed        

  5. ZHU Y, Xia L, Liu C, Lin F, et al
    Uniportal Single-Direction Thoracoscopic Right S9 Segmentectomy: Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2021;28:6407.
    PubMed         Abstract available

  6. NISHINO T, Toba H, Yoshida T, Inoue S, et al
    Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer.
    Ann Surg Oncol. 2021;28:6398-6406.
    PubMed         Abstract available

  7. LEPPELMANN KS, Levesque VM, Bunck AC, Cahalane AM, et al
    Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
    Ann Surg Oncol. 2021;28:5829-5839.
    PubMed         Abstract available


    Ann Thorac Surg

  8. KAGIMOTO A, Tsutani Y, Kushitani K, Kai Y, et al
    Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
    Ann Thorac Surg. 2021;112:935-943.
    PubMed         Abstract available

  9. WALTERS SL, Canavan ME, Salazar MC, Resio BJ, et al
    A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors.
    Ann Thorac Surg. 2021;112:921-927.
    PubMed         Abstract available

  10. RODRIGUEZ M, Dezube AR, Bravo-Iniguez CE, Fox S, et al
    Impact of Neoadjuvant Chemoradiation on Adverse Events After Bronchial Sleeve Resection.
    Ann Thorac Surg. 2021;112:890-896.
    PubMed         Abstract available

  11. TANE S, Kimura K, Shimizu N, Kitamura Y, et al
    Segmentectomy for inner location small-sized non-small-cell lung cancer: Is it feasible?
    Ann Thorac Surg. 2021 Sep 23. pii: S0003-4975(21)01595.
    PubMed         Abstract available

  12. BERRY MF
    Treatment for Early-Stage Lung Cancer Should Never Be "Just a Wedge".
    Ann Thorac Surg. 2021 Sep 25. pii: S0003-4975(21)01658.
    PubMed        


    Anticancer Res

  13. SON KH, Kim MY, Shin JY, Kim JO, et al
    Synergistic Antitumor Effect of Taxanes and CDK4/6 Inhibitor in Lung Cancer Cells and Mice Harboring KRAS Mutations.
    Anticancer Res. 2021;41:4807-4820.
    PubMed         Abstract available

  14. HAMADA K, Yoshimura K, Hirasawa Y, Hosonuma M, et al
    Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy.
    Anticancer Res. 2021;41:4985-4993.
    PubMed         Abstract available

  15. MATSUBARA T, Hirai F, Yamaguchi M, Hamatake M, et al
    Immunonutritional Indices in Non-small-cell Lung Cancer Patients Receiving Adjuvant Platinum-based Chemotherapy.
    Anticancer Res. 2021;41:5157-5163.
    PubMed         Abstract available

  16. MITSUYA S, Tsuruoka K, Kanaoka K, Funamoto T, et al
    Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis.
    Anticancer Res. 2021;41:5137-5145.
    PubMed         Abstract available


    BMC Cancer

  17. HUANG CC, Lai CY, Tsai CH, Wang JY, et al
    Combined effects of cigarette smoking, DNA methyltransferase 3B genetic polymorphism, and DNA damage on lung cancer.
    BMC Cancer. 2021;21:1066.
    PubMed         Abstract available


    Br J Cancer

  18. BRAGA A, Elias KM, Horowitz NS, Berkowitz RS, et al
    When less is more: regarding the use of chest X-ray instead of computed tomography in screening for pulmonary metastasis in postmolar gestational trophoblastic neoplasia.
    Br J Cancer. 2021 Jan 8. pii: 10.1038/s41416-020-01209.
    PubMed         Abstract available

  19. SHIRASAWA M, Yoshida T, Horinouchi H, Kitano S, et al
    Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
    Br J Cancer. 2021;124:925-932.
    PubMed         Abstract available

  20. JIA L, Ge X, Du C, Chen L, et al
    EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-beta/SMAD signalling.
    Br J Cancer. 2021;124:1301-1311.
    PubMed         Abstract available

  21. BARCLAY ME, Abel GA, Greenberg DC, Rous B, et al
    Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its population impact.
    Br J Cancer. 2021 Feb 9. pii: 10.1038/s41416-021-01279.
    PubMed         Abstract available


    Cancer Cell

  22. SANCLEMENTE M, Nieto P, Garcia-Alonso S, Fernandez-Garcia F, et al
    RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression.
    Cancer Cell. 2021;39:294-296.
    PubMed        

  23. GAY CM, Stewart CA, Park EM, Diao L, et al
    Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
    Cancer Cell. 2021;39:346-360.
    PubMed         Abstract available

  24. XIAO Y, Cong M, Li J, He D, et al
    Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation.
    Cancer Cell. 2020 Dec 31. pii: S1535-6108(20)30660.
    PubMed         Abstract available

  25. SRIVASTAVA S, Furlan SN, Jaeger-Ruckstuhl CA, Sarvothama M, et al
    Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade.
    Cancer Cell. 2021;39:193-208.
    PubMed         Abstract available


    Carcinogenesis

  26. JIANG T, Wu H, Lin M, Yin J, et al
    B4GALNT1 promotes progression and metastasis in lung adenocarcinoma through JNK/c-Jun/Slug pathway.
    Carcinogenesis. 2021;42:621-630.
    PubMed         Abstract available

  27. GUI HX, Peng J, Yang ZP, Chen LY, et al
    HDAC1-Smad3-mSin3A complex is required for Smad3-induced transcriptional inhibition of hepatocyte growth factor receptor in human lung cancers.
    Carcinogenesis. 2021;42:587-600.
    PubMed         Abstract available


    Chest

  28. SAINZ ZUNIGA PV, Martinez-Zayas G, Molina S, Grosu HB, et al
    Is Biopsy of Contralateral Hilar N3 Lymph Nodes With Negative PET-CT Scan Findings Necessary When Performing Endobronchial Ultrasound Staging?
    Chest. 2021;159:1642-1651.
    PubMed         Abstract available


    Clin Lung Cancer

  29. JIN Y, Xue Q, Shen X, Zheng Q, et al
    PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort.
    Clin Lung Cancer. 2021 Aug 28. pii: S1525-7304(21)00213.
    PubMed         Abstract available

  30. SEITLINGER J, Prieto M, Guerrera F, Streit A, et al
    Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes.
    Clin Lung Cancer. 2021 Aug 22. pii: S1525-7304(21)00205.
    PubMed         Abstract available

  31. MYNARD N, Saxena A, Mavracick A, Port J, et al
    Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.
    Clin Lung Cancer. 2021 Aug 29. pii: S1525-7304(21)00214.
    PubMed         Abstract available


    Eur J Cancer

  32. MALAPELLE U, Passiglia F, Cremolini C, Reale ML, et al
    RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.
    Eur J Cancer. 2021;146:74-83.
    PubMed         Abstract available


    Eur Respir J

  33. HENROT P, Beaufils F, Thumerel M, Eyraud E, et al
    Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?
    Eur Respir J. 2021 Sep 24. pii: 13993003.01221-2021.
    PubMed        


    Int J Cancer

  34. HUANG Y, Soon YY, Aminkeng F, Tay SH, et al
    Risk factors for Immune-related Adverse Events from anti-PD-1 or anti PD-L1 treatment in an Asian cohort of non-small cell lung cancer patients.
    Int J Cancer. 2021 Sep 25. doi: 10.1002/ijc.33822.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  35. AMINI A, Verma V, Simone CB 2nd, Chetty IJ, et al
    American Radium Society Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Sep 24. pii: S0360-3016(21)02823.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  36. ROCHA ALG, da Conceicao MAM, da Cunha Sequeira Mano FXP, Martins HC, et al
    Metabolic active tumour volume quantified on [(18)F]FDG PET/CT further stratifies TNM stage IV non-small cell lung cancer patients.
    J Cancer Res Clin Oncol. 2021 Sep 27. pii: 10.1007/s00432-021-03799.
    PubMed         Abstract available


    J Surg Oncol

  37. SMITH A, Wali A, Montes A, Hadaki M, et al
    Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.
    J Surg Oncol. 2021 Sep 27. doi: 10.1002/jso.26691.
    PubMed         Abstract available


    J Thorac Oncol

  38. ZATONSKI WA, Janik-Koncewicz K, Zatonski M
    Role of Primary Prevention in Lung Cancer Control in Poland.
    J Thorac Oncol. 2021;16:e93-e94.
    PubMed        

  39. OCAK S, Tournoy K, Berghmans T, Demedts I, et al
    Lung Cancer in Belgium.
    J Thorac Oncol. 2021;16:1610-1621.
    PubMed        

  40. DZIADZIUSZKO R, Didkowska J, Jassem J
    Authors' Reply to Role of Primary Prevention in Lung Cancer Control in Poland.
    J Thorac Oncol. 2021;16:e94-e95.
    PubMed        


    Lung Cancer

  41. HARADA G, Santini FC, Wilhelm C, Drilon A, et al
    NTRK fusions in lung cancer: From biology to therapy.
    Lung Cancer. 2021;161:108-113.
    PubMed         Abstract available

  42. BALATA H, Ruparel M, O'Dowd E, Ledson M, et al
    Analysis of the baseline performance of five UK lung cancer screening programmes.
    Lung Cancer. 2021;161:136-140.
    PubMed         Abstract available

  43. BARANY N, Rozsas A, Megyesfalvi Z, Grusch M, et al
    Clinical relevance of circulating activin A and follistatin in small cell lung cancer.
    Lung Cancer. 2021;161:128-135.
    PubMed         Abstract available

  44. AULIAC JB, Monnet I, Bizieux A, Greillier L, et al
    Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study).
    Lung Cancer. 2021;161:122-127.
    PubMed         Abstract available

  45. TU Z, Li C, Tian T, Chen Q, et al
    A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion.
    Lung Cancer. 2021;161:114-121.
    PubMed         Abstract available


    Mol Cancer Ther

  46. YIN L, Zhang Y, Yin L, Ou Y, et al
    Novel mitochondria-based targeting restores responsiveness in therapeutically resistant human lung cancer cells.
    Mol Cancer Ther. 2021 Sep 28. pii: 1535-7163.MCT-20-1095.
    PubMed         Abstract available


    Mol Carcinog

  47. XIAO M, Cui S, Zhang L, Yu T, et al
    Benzo[a]pyrene diol epoxide-induced transformed cells identify the significance of hsa_circ_0051488, a ERCC1-derived circular RNA in pulmonary squamous cell carcinoma.
    Mol Carcinog. 2021;60:684-701.
    PubMed         Abstract available


    Oncologist

  48. GOSSLING GCL, Chedid MF, Pereira FS, da Silva RK, et al
    Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience.
    Oncologist. 2021;26:e1581-e1588.
    PubMed         Abstract available


    PLoS One

  49. CHMIELEWSKA I, Dudzinska M, Szczyrek M, Swirska J, et al
    Do endocrine adverse events predict longer progression-free survival among patients with non-small-cell lung cancer receiving nivolumab?
    PLoS One. 2021;16:e0257484.
    PubMed         Abstract available

  50. MOK PL, Anandasayanam ANK, Oscar David HM, Tong J, et al
    Lung development, repair and cancer: A study on the role of MMP20 gene in adenocarcinoma.
    PLoS One. 2021;16:e0250552.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: